MDT vs ABT
MDT and ABT side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MDTMedtronic plc | ABTABBOTT LABORATORIES |
|---|---|---|
| Market cap | $112.09B | $189.22B |
| P/E (TTM) | 23.5 | 30.4 |
| P/B | 2.27 | 3.63 |
| P/S | 3.1x | 4.2x |
| Dividend yield | 3.25% | 2.18% |
| Revenue | $36.36B(TTM) | $45.13B(TTM) |
| Revenue growth (YoY) | 8.4% | 5.7% |
| Net income | $4.80B(TTM) | $6.28B(TTM) |
| Earnings growth (YoY) | 3.0% | -51.3% |
| EPS, diluted | $3.73(TTM) | $3.57(TTM) |
| EBIT margin | 17.8% | 18.2% |
| ROE | 9.7% | 12.5% |
| ROIC | 7.1% | 8.3% |
| Piotroski F | 8/9 | — |
| 1y total return | -3.0% | -14.4% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: MDT vs ABT
| 지표 | MDT | ABT |
|---|---|---|
| 최종 가치 | $15.2K | $32.5K |
| 총수익률 | +51.5% | +224.7% |
| CAGR | +4.1% | +12.1% |
| 변동성 | 23.2% | 23.9% |
| 샤프 | 0.12 | 0.43 |
| 소르티노 | 0.17 | 0.62 |
| 최대 낙폭 | -45.3% | -39.6% |
공통 거래일 2600일 기준, 2016-03-28 → 2026-07-29 · 무위험수익률 3.9% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)